Cargando…

A novel role for kynurenine 3-monooxygenase in mitochondrial dynamics

The enzyme kynurenine 3-monooxygenase (KMO) operates at a critical branch-point in the kynurenine pathway (KP), the major route of tryptophan metabolism. As the KP has been implicated in the pathogenesis of several human diseases, KMO and other enzymes that control metabolic flux through the pathway...

Descripción completa

Detalles Bibliográficos
Autores principales:	Maddison, Daniel C., Alfonso-Núñez, Mónica, Swaih, Aisha M., Breda, Carlo, Campesan, Susanna, Allcock, Natalie, Straatman-Iwanowska, Anna, Kyriacou, Charalambos P., Giorgini, Flaviano
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7654755/ https://www.ncbi.nlm.nih.gov/pubmed/33170836 http://dx.doi.org/10.1371/journal.pgen.1009129

Ejemplares similares

Kynurenine 3-Monooxygenase Interacts with Huntingtin at the Outer Mitochondrial Membrane
por: Swaih, Aisha M., et al.
Publicado: (2022)

Structural basis of kynurenine 3-monooxygenase inhibition
por: Amaral, Marta, et al.
Publicado: (2013)

Rab11 rescues synaptic dysfunction and behavioural deficits in a Drosophila model of Huntington's disease
por: Steinert, Joern R., et al.
Publicado: (2012)

Inflammation control and improvement of cognitive function in COVID-19 infections: is there a role for kynurenine 3-monooxygenase inhibition?
por: Collier, Mary EW, et al.
Publicado: (2021)

Cellular Localization of Kynurenine 3-Monooxygenase in the Brain: Challenging the Dogma
por: Sathyasaikumar, Korrapati V., et al.
Publicado: (2022)

Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
por: Bondulich, Marie Katrin, et al.
Publicado: (2021)

A brain-permeable inhibitor of the neurodegenerative disease target kynurenine 3-monooxygenase prevents accumulation of neurotoxic metabolites
por: Zhang, Shaowei, et al.
Publicado: (2019)

The Kynurenine Pathway and Kynurenine 3-Monooxygenase Inhibitors
por: Hughes, Tamera D., et al.
Publicado: (2022)

Modulation of Enzyme Activity in the Kynurenine Pathway by Kynurenine Monooxygenase Inhibition
por: Phillips, Robert S., et al.
Publicado: (2019)

Kynurenine 3-Monooxygenase: An Influential Mediator of Neuropathology
por: Parrott, Jennifer M., et al.
Publicado: (2015)

Kynurenine Monooxygenase Expression and Activity in Human Astrocytomas
por: Vázquez Cervantes, Gustavo Ignacio, et al.
Publicado: (2021)

Significance of Kynurenine 3-Monooxygenase Expression in Colorectal Cancer
por: Liu, Chun-Yu, et al.
Publicado: (2021)

Rab11 modulates α-synuclein-mediated defects in synaptic transmission and behaviour
por: Breda, Carlo, et al.
Publicado: (2015)

Bacterial expression of human kynurenine 3-monooxygenase: Solubility, activity, purification()
por: Wilson, K., et al.
Publicado: (2014)

Kynurenine‐3‐monooxygenase: A new direction for the treatment in different diseases
por: Lu, Yifei, et al.
Publicado: (2020)

Mycobacterial phosphatase PstP regulates global serine threonine phosphorylation and cell division
por: Iswahyudi, et al.
Publicado: (2019)

Kynurenine 3-monooxygenase is a critical regulator of renal ischemia–reperfusion injury
por: Zheng, Xiaozhong, et al.
Publicado: (2019)

Blockade of KAT II Facilitates LTP in Kynurenine 3-Monooxygenase Depleted Mice
por: Imbeault, Sophie, et al.
Publicado: (2021)

Full-length in meso structure and mechanism of rat kynurenine 3-monooxygenase inhibition
por: Mimasu, Shinya, et al.
Publicado: (2021)

Kynurenine–3–monooxygenase inhibition prevents multiple organ failure in rodent models of acute pancreatitis
por: Mole, Damian J, et al.
Publicado: (2016)

Diclofenac Identified as a Kynurenine 3-Monooxygenase Binder and Inhibitor by Molecular Similarity Techniques
por: Shave, Steven, et al.
Publicado: (2018)

Structural and mechanistic basis of differentiated inhibitors of the acute pancreatitis target kynurenine-3-monooxygenase
por: Hutchinson, Jonathan P., et al.
Publicado: (2017)

Protective Role of Kynurenine 3-Monooxygenase in Allograft Rejection and Tubular Injury in Kidney Transplantation
por: Lassiter, Randi, et al.
Publicado: (2021)

Prognostic significance of kynurenine 3-monooxygenase and effects on proliferation, migration, and invasion of human hepatocellular carcinoma
por: Jin, Haojie, et al.
Publicado: (2015)

Viability of diffuse large B-cell lymphoma cells is regulated by kynurenine 3-monooxygenase activity
por: Morita, Nanaka, et al.
Publicado: (2021)

Surface Expression of Kynurenine 3-Monooxygenase Promotes Proliferation and Metastasis in Triple-Negative Breast Cancers
por: Lai, Min-Hua, et al.
Publicado: (2021)

Protocatechuic acid prevents isoproterenol‐induced heart failure in mice by downregulating kynurenine‐3‐monooxygenase
por: Bai, Liyan, et al.
Publicado: (2023)

Nitric oxide-mediated posttranslational modifications control neurotransmitter release by modulating complexin farnesylation and enhancing its clamping ability
por: Robinson, Susan W., et al.
Publicado: (2018)

Drosophila Nrf2/Keap1 Mediated Redox Signaling Supports Synaptic Function and Longevity and Impacts on Circadian Activity
por: Spiers, Jereme G., et al.
Publicado: (2019)

Esculetin Provides Neuroprotection against Mutant Huntingtin-Induced Toxicity in Huntington’s Disease Models
por: Pruccoli, Letizia, et al.
Publicado: (2021)

Kynurenine pathway metabolites in cerebrospinal fluid and blood as potential biomarkers in Huntington's disease
por: Rodrigues, Filipe B., et al.
Publicado: (2021)

Pharmacological Inhibition of Indoleamine 2,3-Dioxygenase-2 and Kynurenine 3-Monooxygenase, Enzymes of the Kynurenine Pathway, Significantly Diminishes Neuropathic Pain in a Rat Model
por: Rojewska, Ewelina, et al.
Publicado: (2018)

The Kynurenine 3-Monooxygenase Encoding Gene, BcKMO, Is Involved in the Growth, Development, and Pathogenicity of Botrytis cinerea
por: Zhang, Kang, et al.
Publicado: (2018)

Peripheral kynurenine-3-monooxygenase deficiency as a potential risk factor for metabolic syndrome in schizophrenia patients
por: Oxenkrug, Gregory, et al.
Publicado: (2017)

Pharmacophore-Based Virtual Screening of Novel Competitive Inhibitors of the Neurodegenerative Disease Target Kynurenine-3-Monooxygenase
por: Gotina, Lizaveta, et al.
Publicado: (2021)

Parkinson’s disease-associated mutations in DJ-1 modulate its dimerization in living cells
por: Repici, Mariaelena, et al.
Publicado: (2012)

Overexpression of Kynurenine 3-Monooxygenase Correlates with Cancer Malignancy and Predicts Poor Prognosis in Canine Mammary Gland Tumors
por: Chiu, Yi-Han, et al.
Publicado: (2019)

Integrated Molecular Characterization to Reveal the Association between Kynurenine 3-Monooxygenase Expression and Tumorigenesis in Human Breast Cancers
por: Tsang, Yuk-Wah, et al.
Publicado: (2021)

Generation of Distinct Differentially Culturable Forms of Burkholderia following Starvation at Low Temperature
por: Auty, Joss M., et al.
Publicado: (2022)

Overexpression of human kynurenine-3-monooxygenase protects against 3-hydroxykynurenine-mediated apoptosis through bidirectional nonlinear feedback
por: Wilson, K, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_svv6liqftq8elcn87d4ma7g0ov